Journal
/
Quimica
/
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
JoVE Revista
Quimica
Se requiere una suscripción a JoVE para ver este contenido.  Inicie sesión o comience su prueba gratuita.
JoVE Revista Quimica
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

9,909 Views

•

09:44 min

•

January 29, 2019

DOI:

10.3791/59041-v

DOI:
10.3791/59041-v

•

09:44 min
January 29, 2019

•

2 Views
, ,
1Department of Chemistry,Hunter College of the City University of New York, 2Ph.D. Program in Chemistry,Graduate Center of the City University of New York, 3Department of Radiology,Memorial Sloan Kettering Cancer Center, 4Department of Radiology,Weill Cornell Medical College

Summary

Automatically generated

This protocol describes the synthesis and characterization of a trans-cyclooctene (TCO)-modified antibody and a 177Lu-labeled tetrazine (Tz) radioligand for pretargeted radioimmunotherapy (PRIT). In addition, it details the use of these two constructs for in vivo biodistribution and longitudinal therapy studies in a murine model of colorectal cancer.

Explore More Videos

Pretargeted RadioimmunotherapyPRITInverse Electron Demand Diels-Alder ReactionColorectal Cancer XenograftAntibody ConjugationTCO-NHSHuA33 AntibodySize Exclusion ChromatographyUV-vis Spectrophotometry

Read Article

Cite this Article

Membreno, R., Cook, B. E., Zeglis, B. M. Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction. J. Vis. Exp. (143), e59041, doi:10.3791/59041 (2019).

Download .ris file

Copy

Share Video

.

Copy